Kendal Broadie, Ph.D., Director of Neurobiology and Brain Plasticity Research Program
Genetic analysis of kidline cell fate specification—National Institute of Child Health and Human Development (1999-2004)
Bruce Appel, Ph.D., Principal Investigator
Neurological function of fragile X gene in the drosophila genetic model system—National Institute of Child Health and Human Development (2001-2006)
Kendal Broadie, Ph.D., Principal Investigator
Genetic analysis of synapse formation and function—National Institute of General Medical Sciences (1997-2006)
Kendal Broadie, Ph.D., Principal Investigator
Synaptic mechanisms of neurodegenerative disease—National Institute of Neurological Disorders and Stroke (2001-2005)
Kendal Broadie, Ph.D., Principal Investigator
Visual system organization and development—National Eye Institute (1978-2008)
Vivien Casagrande, Ph.D., Principal Investigator
Cognitive control of thalamic activity—National Science Foundation (2003-2005)
Vivien Casagrande, Ph.D., Principal Investigator
Mechanisms of CaM kinase II signal transduction—National Institute of Mental Health (2001-2006)
Roger Colbran, Ph.D., Principal Investigator
Targeting of brain protein phosphatase 1—National Institute of Neurological Disorders and Stroke (1998-2003)
Roger Colbran, Ph.D., Principal Investigator
Project 2: Modulation of dendritic CaMKII by dopamine--—National Institute of Neurological Disorders and Stroke (2002-2007)
Roger Colbran, Ph.D., Principal Investigator
Dopamine system interactions and schizophrenia—National Institute of Mental Health (1998-2004)
Ariel Deutch, Ph.D., Principal Investigator
Monoaminergic regulation of GABA and schizophrenia—National Institute of Mental Health (1997-2005)
Ariel Deutch, Ph.D., Principal Investigator
Project 1: Dopamine and dendritic spines--National Institute of Neurological Disorders and Stroke (2002-2007)
Ariel Deutch, Ph.D., Principal Investigator
Neuroplasticity after cortical injury--National Institute of Neurological Disorders and Stroke (1979-2004)
Ford Ebner, Ph.D., Principal Investigator
Plasticity of barrel field intracortical circuitry--National Institute of Neurological Disorders and Stroke (1988-2003)
Ford Ebner, Ph.D., Principal Investigator
Regulation of RNA editing in the CNS--National Institute of Neurological Disorders and Stroke (1995-2004)
Ronald Emeson, Ph.D., Principal Investigator
Hereditary defects in human sodium channels—National Institute of Neurological Disorders and Stroke (1994-2006)
Alfred George, Jr., M.D., Principal Investigator
Proton relaxation and contrast mechanisms in MRI (1985-2004)
John Gore, Ph.D., Principal Investigator
Integrated functional imaging of the human brain (2002-2007)
John Gore, Ph.D., Principal Investigator
Biophysical basis of functional brain MRI—National Institute of Neurological Disorders and Stroke (1995-2004)
John Gore, Ph.D., Principal Investigator
Functional organization of the somatosensory system--National Institute of Neurological Disorders and Stroke (1980-2005)
Jon Kaas, Ph.D., Principal Investigator
Brain structure and function after fetal cocaine exposure—National Institute on Drug Abuse (1996-2006)
Pat Levitt, Ph.D., Principal Investigator, Gregg Stanwood, Ph.D.
Fetal cocaine and gene expression defects in forebrain—National Institute on Drug Abuse (2000-2004)
Pat Levitt, Ph.D., Principal Investigator, Gregg Stanwood, Ph.D.
Project 2: Gene expression patterns in prefrontal cortical injury—National Institute of Mental Health (1990-2003)
Pat Levitt, Ph.D., Principal Investigator
Factors regulating limbic system assembly—National Institute of Mental Health (1989-2004)
Pat Levitt, Ph.D., Principal Investigator
Function and structure adaptation in forebrain development—National Institute of Mental Health (2002-2007)
Pat Levitt, Ph.D., Principal Investigator
In vivo relevance of alpha2AR trafficking itineraries—National Heart, Lung, and Blood Institute (1995-2004)
Lee Limbird, Ph.D., Principal Investigator
Mechanisms for GPCR trafficking in polarized cells—National Institute of Diabetes and Digestive and Kidney Diseases (1993-2004)
Lee Limbird, Ph.D., Principal Investigator
Proteomic analysis of eukaryotic protein synthesis—National Institute of General Medical Sciences (2002-2007)
Andrew Link, Ph.D., Principal Investigator
Mechanisms of retinal synaptic plasticity—National Eye Institute (1991-2003)
Douglas McMahon, Ph.D., Principal Investigator
Molecular physiology of circadian pacemaking—National Institute of Mental Health (2001-2006)
Douglas McMahon, Ph.D., Principal Investigator
Mitochondrial fatty acid oxidation disorders and arrhythmogenesis-- National Institute of Diabetes and Digestive and Kidney Diseases (2000-2004)
Arnold Strauss, M.D., Principal Investigator
Ethanol inhibition of NMDA receptor mediated responses—National Institute of Alcohol Abuse and Alcoholism (1991-2005)
Danny Winder, Ph.D., Principal Investigator, Roger Colbran, Ph.D.
Project 3: Regulation of striatal plasticity by phosphates-- National Institute of Neurological Disorders and Stroke (2002-2007)
Danny Winder, Ph.D., Principal Investigator
Regulation of LTP by Gi linked receptors—National Institute of Drug Abuse (2001-2006)
Danny Winder, Ph.D., Principal Investigator